Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU7-195P is a pseudogene corresponding to the U7 small nuclear RNA family in humans. U7 small nuclear RNA (U7 snRNA) is normally a component of the U7 small nuclear ribonucleoprotein (snRNP) complex, which is involved in the 3′-end processing of replication-dependent histone pre-mRNAs in metazoans[1][2][3]. However, RNU7-195P does not encode a functional RNA molecule. Pseudogenes like RNU7-195P are generally non-functional copies of genes and do not contribute to cellular processes or disease phenotypes[5]. No aliases, functional classifications, or interactions are reported for RNU7-195P in major genetics and genome resources[5][6]. RNU7-195P is a pseudogene and not a functional RNA or protein-coding gene, nor is it a valid therapeutic target. There are no aliases, functions, disease roles, or drug interactions associated with it[5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U7 small nuclear 195 pseudogene (RNU7-195P).